Latest filing published 15 Jul 2026 for Monte Rosa Therapeutics, Inc., €89k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Champoux Jennifer in Monte Rosa Therapeutics, Inc. We count 3 filings; the first trade dates from 17 June 2026 and the latest from 15 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 15 July 2026 with a transaction (€89k) in Monte Rosa Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations